Crescent Biopharma, Inc. (CBIO) — Free Cash Flow Generation Index

Latest as of September 2015: 1.00x

Crescent Biopharma, Inc. (CBIO) has a Free Cash Flow Generation Index of 1.00x as of September 2015. Free cash flow of $13.51 Million represents 1% of operating cash flow ($13.56 Million). Explore Crescent Biopharma, Inc. (CBIO) reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.

FCF Generation Index

1.00x
Free Cash Flow / Operating CF

Free Cash Flow

$13.51 Million
USD

Operating Cash Flow

$13.56 Million
USD

Capital Expenditures

$58.39K
USD

Crescent Biopharma, Inc. Free Cash Flow Generation Index (2011–2011)

Historical FCF Generation Index trend for Crescent Biopharma, Inc. across 1 annual periods. For the full cash flow conversion analysis, see how efficiently does Crescent Biopharma, Inc. generate cash.

Annual Free Cash Flow Generation for Crescent Biopharma, Inc. (2011–2011)

Year-by-year Free Cash Flow Generation Index for Crescent Biopharma, Inc.. Check Crescent Biopharma, Inc. total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.

Year FCG Index Free Cash Flow (USD) Operating CF Capital Expenditures YoY Change
2011 0.99x $13.67 Million $13.85 Million $182.44K
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).